It looks like you're using an Ad Blocker.

Please white-list or disable in your ad-blocking tool.

Thank you.


Some features of ATS will be disabled while you continue to use an ad-blocker.


USA Military History Of Research On Coronavirus And Related Deadly Pathogens

page: 1

log in


posted on Apr, 15 2020 @ 04:46 AM
This thread is not to blame anyone for the current pandemic. This thread is for those interested to look at the research that has been going on and keep informed as to what our government has been doing with virus research.

Ok so I was looking up some coronavirus research the US has been doing in the past primarily within the USA however a lot of biological weapon research is done in foreign countries due to laws and such but that's not really the focus of this thread. The primary purpose is to inform interested readers. I think this research is very dangerous and would prefer if it didn't happen. To be honest I was pretty shocked to see we made the corona virus into a more deadly pathogen capable of infecting humans.
Anyways what do you guys and gals this of the research we have done so far? Should it continue?
Personally I think it should be stopped.

The US Will Fund Research to Make Pathogens Deadlier Again
The NIH lifted a 3-year funding moratorium on “gain-of-function” research meant to make deadly viruses stronger and more transmissible.

An experiment that created a hybrid version of a bat coronavirus — one related to the virus that causes SARS (severe acute respiratory syndrome) — has triggered renewed debate over whether engineering lab variants of viruses with possible pandemic potential is worth the risks.

ARPA spent $10 mil­lion on one project in 2018 ‘to unrav­el the com­plex caus­es of bat-borne virus­es that have recent­ly made the jump to humans, caus­ing con­cern among glob­al health offi­cials.” Anoth­er research project backed by both DARPA and NIH saw researchers at Col­orado State Uni­ver­si­ty exam­ine the coro­n­avirus that caus­es Mid­dle East Res­pi­ra­to­ry Syn­drome (MERS) in bats and camels ‘to under­stand the role of these hosts in trans­mit­ting dis­ease to humans.’ -53ff-87da-3d9c2466cd61.html

Researchers at Col­orado State Uni­ver­si­ty exam­ine the coro­n­avirus that caus­es Mid­dle East Res­pi­ra­to­ry Syn­drome (MERS) in bats and camels ‘to under­stand the role of these hosts in trans­mit­ting dis­ease to humans.

DARPA’s Preventing Emerging Pathogenic Threats, or PREEMPT program, which was officially announced in April 2018. PREEMPT focuses specifically on animal reservoirs of disease, specifically bats, and DARPA even noted in its press release in the program that it “is aware of biosafety and biosecurity sensitivities that could arise” due to the nature of the research.

Department of Defense’s Cooperative Threat Reduction Program — began funding research involving bats and deadly pathogens, including the coronaviruses MERS and SARS, a year prior in 2017.

US diplomats involved in trafficking of human blood and pathogens for secret military program

All research at a Fort Detrick laboratory that handles high-level disease-causing material, such as Ebola, is on hold indefinitely after the Centers for Disease Control and Prevention found the organization failed to meet biosafety standards. Also recently been involved in research borne out of the Pentagon’s recent concern about the use of bats as bioweapons. 6d.html
CDC Approves Partial Resumption of USAMRIID Fort Detrick Select Agent Research

U.S. Nation­al Insti­tute of Health col­lab­o­rat­ed with both the CIA and the Pen­ta­gon on infec­tious dis­ease and bioweapons research

DARPA the top fun­der of the con­tro­ver­sial ‘gene dri­ve’ tech­nol­o­gy to per­ma­nent­ly alter the genet­ics of entire pop­u­la­tions while tar­get­ing oth­ers for extinc­tion.

The JASON group, com­posed of aca­d­e­m­ic sci­en­tists, served as tech­ni­cal advis­ers to the U. S. gov­ern­ment. Their study gen­er­at­ed six broad class­es of genet­i­cal­ly engi­neered pathogens that could pose seri­ous threats to soci­ety. These include but are not lim­it­ed to bina­ry bio­log­i­cal weapons, design­er genes, gene ther­a­py as a weapon, stealth virus­es, host-swap­ping dis­eases, and design­er dis­eases

Scientists fear US military plans to turn insects into vessels for genetically modified viruses could end badly
US military plan to spread viruses using insects could create ‘new class of biological weapon’, scientists warn

edit on 15-4-2020 by FormOfTheLord because: (no reason given)

posted on Apr, 15 2020 @ 08:37 AM
I'm against researching bio-weapons using national defense as an excuse to cover the fact they are developing even deadlier novel viruses that can be used offensively.

I'd say that the risk to benefit ratio tends toward higher risks then real benefits.

If they are tinkering around with these deadly viruses to find defensive strategies, treatments, vaccines and cures, that doesn't mean they will find anything that is very effective or that the particular strains they develop will be the ones that will evolve naturally or get released during a bio-attack.

Overall, I'd say the risks outweigh the benefits with regards to playing around with deadly viral pathogens. They create the problem, then try to find the solution after the fact, a method IMO that is bound to backfire and get out of control.

It should be enough to know how these viruses work and limit the research to naturally occurring outbreaks without weaponizing them in the process. Is that too much to ask?
edit on 15-4-2020 by MichiganSwampBuck because: Added extra comments

posted on Apr, 15 2020 @ 08:44 AM
Back in the 80's, I spent almost 3 years at Ft. Detrick, Md. Home of:

Since 1969, USAMRIID has served as the Department of Defense's (DoD) lead laboratory for medical biological defense research. While our core mission is to protect the warfighter from biological threats, we also investigate disease outbreaks and threats to public health. Research conducted at USAMRIID leads to medical solutions—therapeutics, vaccines, diagnostics, and information—that benefit both military personnel and civilians. USAMRIID is a subordinate laboratory of the U.S. Army Medical Research and Development Command.

This is where we got our flu shots. We never thought the annual flu shots were for the flu. We were unwilling lab rats.

posted on Apr, 15 2020 @ 08:57 AM
a reply to: RickinVa

Alot has been moved to Silver Springs since then.

posted on Apr, 15 2020 @ 09:10 AM
a reply to: DBCowboy


posted on Apr, 15 2020 @ 09:12 AM

originally posted by: RickinVa
a reply to: DBCowboy


More USAMMA but I wouldn't be surprised if USAMRIID has shifted some.

posted on Apr, 15 2020 @ 09:15 AM
The US could of been researching a vaccine to fight a potential threat in the midst.

a reply to: FormOfTheLord

posted on Apr, 15 2020 @ 09:22 AM
a reply to: FormOfTheLord

You are so right.

Here is Paul Craig Roberts' take on it.

posted on Apr, 15 2020 @ 10:04 AM

originally posted by: Ophiuchus 13
The US could of been researching a vaccine to fight a potential threat in the midst.

a reply to: FormOfTheLord

Your correct in that our military believes that due to past research a rapid response will be able to save lives with new technologies. Lets hope that lives are saved.
Since the early 2010s, DARPA has invested in a new type of vaccine technology — nucleic acid vaccines — which use the human body as its “bioreactor” to create the antibodies needed for immunity. DARPA funded this type of vaccine because traditional vaccine manufacturing is cumbersome, Jenkins said, and can take up to 18 months.

DARPA’s efforts on new mRNA vaccines have perhaps led to the best chance of effective immunization against COVID-19. This is in part thanks to a $25 million grant it awarded in 2013 to biotech company Moderna to manufacture mRNA vaccines to protect against a “wide range of known and unknown emerging infectious diseases and engineered biological threats."

In 2018, DARPA signed the first contracts for the Pandemic Prevention Platform (P3) program, a project that aims to create a “medical countermeasure” for a pandemic disease within 60 days of that pathogen’s identification using the mRNA vaccine technology. The platform relies on ongoing research into rapid antibody-discovery technology that must be linked with tech able to quickly manufacture those antibodies.

new topics

top topics


log in